Obesity linked to improved survival in kidney cancer

September 5, 2016, Dana-Farber Cancer Institute
This is an image of a weight scale. Credit: CDC/Debora Cartagena

Obesity almost always increases cancer risk and worsens outcomes, but researchers led by scientists at Dana-Farber Cancer Institute report that overweight patients with advanced kidney cancer had significantly longer survival than those who were normal or underweight.

Having a high body mass index (BMI) is a well-established risk factor for clear cell , the most common type of . (BMI is the ratio of weight in kilograms divided by the squared height in meters.)

Yet, paradoxically, the study published in the Journal of Clinical Oncology involving thousands of patients in four databases demonstrated that when overweight individuals developed kidney cancer - especially in its advanced, metastatic form - their disease progressed more slowly and they lived longer than their normal-weight counterparts.

In one cohort of nearly 2,000 patients, the median overall survival of patients with high BMI (overweight or obese) was 25.6 months compared to 17.1 months for patients with low BMI. The mortality rate for the overweight cancer patients was 16 percent less over the course of the study, which began in 2003.

The report's authors, led by senior and corresponding author Toni K. Choueiri, MD, director of the Lank Center for Genitourinary Oncology at Dana-Farber, noted previous research showed that kidney cancer diagnosed in obese patients had less-dangerous pathological characteristics, and when treated with targeted therapies, these patients, even when their disease had spread, had better overall survival.

In the new study, Choueiri and his colleagues, including first author Laurence Albiges, PhD, formerly a visiting scientist at Dana-Farber, now GU Medical Oncology Lead at Institut Gustave Roussy in France, confirmed these findings in four separate databases, which Choueiri said "makes this a very strong study."

The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) provided records on 1,975 patients who had received targeted therapies. Their height and weight were recorded at the initiation of therapy. In a validation set, the scientists also analyzed pooled data on 4.657 patients treated for kidney cancer in clinical trials between 2003 and 2013.

Another dataset, from The Cancer Genome Atlas project, included clinical and genomic information on 324 kidney cancer patients. The fourth database included cancer tissue samples from 146 kidney cancer patients treated at Dana-Farber and other Harvard-affiliated hospitals. . Using these two databases, the investigators searched for molecular differences between the high- and low-BMI patients that might explain why kidney tumors in obese patients were less aggressive and responded better to treatment.

The TGCA analysis didn't reveal any differences in the tumors' DNA, such as gene mutations, that might account for the disparity. But when the scientists looked at gene expression - the rate at which genetic information was being used by the cell to make proteins - they spotted a difference. Expression of a gene called fatty acid synthase (FASN) was found to be decreased in patients with high BMI compared to normal weight patients. FASN is key enzyme in lipogenesis - cells' production of fatty acids - and overexpression of FASN has previously been found in many types of cancer - so much so that FASN has been called a metabolic oncogene. FASN has been associated with poor prognosis in several types of cancer, including kidney cancer.

Since FASN expression was decreased, or "downregulated," in overweight and obese kidney cancer patients, that could explain why these individuals fared better than those who were of normal weight and had increased FASN gene expression. Why FASN is downregulated in isn't yet known, but the authors of the study say the results provide a rationale for experiments aimed at inhibiting FASN expression in kidney cancer - regardless of their BMI - in an effort to improve outcomes. FASN inhibitors, including some derived from natural products, have been in development for several years and are considered a promising approach to cancer treatment.

"We plan to test FASN inhibitors in an animal model as a possible therapy for kidney cancer," said Choueiri.

Explore further: Study finds surgery can lengthen survival of metastatic kidney cancer patients

Related Stories

Study finds surgery can lengthen survival of metastatic kidney cancer patients

June 20, 2016
Surgery to remove a cancerous kidney can often lengthen the lives of patients receiving targeted therapy for metastatic kidney cancer, but only about three in ten such patients undergo the procedure, according to a new study ...

New drug improves outcome in treatment resistant kidney cancer

September 28, 2015
A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, according to results from a ...

Higher survival rate for overweight colorectal cancer patients than normal-weight patients

May 19, 2016
Overweight colorectal cancer patients were 55 percent less likely to die from their cancer than normal-weight patients who have the disease, according to a new Kaiser Permanente study published today in JAMA Oncology.

Researchers use genetics to probe immune system's role in fighting cancer

August 25, 2016
To better understand the immune system's role in the fight against cancer, University of North Carolina Lineberger Comprehensive Cancer Center researchers have searched thousands of tumors for genetic signatures that might ...

Prevalence of estrogen receptor mutations in patients with metastatic breast cancer

August 11, 2016
A new study published online by JAMA Oncology examines the prevalence and significance of estrogen receptor mutations in patients with metastatic breast cancer.

Thin colorectal cancer patients have shorter survival than obese patients

July 1, 2015
Although being overweight with a high body-mass index (BMI) has long been associated with a higher risk for colorectal cancer, thinner patients might not fare as well after treatment for advanced cancer, according to a new ...

Recommended for you

Daily low-dose aspirin may be weapon against ovarian cancer

July 20, 2018
(HealthDay)— One low-dose aspirin a day could help women avoid ovarian cancer or boost their survival should it develop, two new studies suggest.

Discovery of kidney cancer driver could lead to new treatment strategy

July 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change ...

High fruit and vegetable consumption may reduce risk of breast cancer, especially aggressive tumors

July 19, 2018
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers ...

Sunscreen reduces melanoma risk by 40 per cent in young people

July 19, 2018
A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely ...

Analysis of prostate tumors reveals clues to cancer's aggressiveness

July 19, 2018
Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common. The study lays the foundation ...

Complementary medicine for cancer can decrease survival

July 19, 2018
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.